We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
Cap. Flow
-$1.7B
Cap. Flow %
-1.7%
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170

Sector Composition

Rank Sector Weight
1 Technology 16.9%
2 Industrials 13.89%
3 Financials 12.91%
4 Consumer Discretionary 10.69%
5 Healthcare 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOL
2801
DELISTED
Biolase, Inc.
BIOL
-9
Closed -$8K
AVGR
2802
DELISTED
Avinger, Inc. Common Stock
AVGR
-45
Closed -$6K
ROVR
2803
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
-13,528
Closed -$132K
GRCL
2804
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
-59,910
Closed -$362K
TBLT
2805
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
-2
Closed -$7K
FTCH
2806
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-40,790
Closed -$1.36M
SCU
2807
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
-183,182
Closed -$3.91M
ARGO
2808
DELISTED
Argo Group International Holdings, Ltd.
ARGO
-12,052
Closed -$700K
EMAN
2809
DELISTED
eMagin Corporation
EMAN
-10,045
Closed -$13K
CELL
2810
DELISTED
PhenomeX Inc. Common Stock
CELL
-80,149
Closed -$1.46M
SURF
2811
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-328,228
Closed -$1.57M
HGEN
2812
DELISTED
HUMANIGEN, INC.
HGEN
-18,131
Closed -$67K
DSEY
2813
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
-10,159
Closed -$135K
USX
2814
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-338,483
Closed -$1.99M
CSII
2815
DELISTED
Cardiovascular Systems, Inc.
CSII
-60,406
Closed -$1.13M
TIG
2816
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
-252,506
Closed -$2.25M
AGRX
2817
DELISTED
Agile Therapeutics
AGRX
-7
Closed -$7K
DCT
2818
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
-9,221
Closed -$278K
ELOX
2819
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
-270
Closed -$8K
IS
2820
DELISTED
ironSource Ltd.
IS
-182,760
Closed -$1.42M
RNDB
2821
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
-138,497
Closed -$3.31M
CDR
2822
DELISTED
Cedar Realty Trust, Inc
CDR
-52,900
Closed -$1.33M
FOE
2823
DELISTED
Ferro Corporation
FOE
-10,352
Closed -$226K
DHR.PRA
2824
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
-6,926
Closed -$15.2M
ZSAN
2825
DELISTED
Zosano Pharma Corporation
ZSAN
-487
Closed -$8K

Similar funds

Victory Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
  • Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
  • Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
  • Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
  • Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
  • Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
  • Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.